Cargando…
Autonomous Targeting of Infectious Superspreaders Using Engineered Transmissible Therapies
Infectious disease treatments, both pharmaceutical and vaccine, face three universal challenges: the difficulty of targeting treatments to high-risk ‘superspreader’ populations who drive the great majority of disease spread, behavioral barriers in the host population (such as poor compliance and ris...
Autores principales: | Metzger, Vincent T., Lloyd-Smith, James O., Weinberger, Leor S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060167/ https://www.ncbi.nlm.nih.gov/pubmed/21483468 http://dx.doi.org/10.1371/journal.pcbi.1002015 |
Ejemplares similares
-
Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility
por: Zhao, Shi, et al.
Publicado: (2022) -
An open-access database of infectious disease transmission trees to explore superspreader epidemiology
por: Taube, Juliana C., et al.
Publicado: (2022) -
Finding the infectious dose for COVID-19 by applying an airborne-transmission model to superspreader events
por: Prentiss, Mara, et al.
Publicado: (2022) -
Superspreading in early transmissions of COVID-19 in Indonesia
por: Hasan, Agus, et al.
Publicado: (2020) -
Superspreading and the effect of individual variation on disease emergence
por: Lloyd-Smith, J. O., et al.
Publicado: (2005)